Cargando…

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy

SIMPLE SUMMARY: Cancerous cells acquire genetic mutations that can lead to changes in the amino acid sequence of proteins. These altered amino acid sequences, or “neoantigens” allow the immune system to recognize the mutated cells as “non-self” and eliminate them. This review outlines discoveries th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verdon, Daniel J., Jenkins, Misty R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391927/ https://www.ncbi.nlm.nih.gov/pubmed/34439399 http://dx.doi.org/10.3390/cancers13164245

Ejemplares similares

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
por: Okada, Masahiro, et al.
Publicado: (2022)

Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021)

Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
por: Brancati, Valentina Urzì, et al.
Publicado: (2023)

Cancer neoantigens as potential targets for immunotherapy
por: Ma, Weijie, et al.
Publicado: (2021)

New emerging targets in cancer immunotherapy: the role of neoantigens
por: De Mattos-Arruda, Leticia, et al.
Publicado: (2020)

Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020)

Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
por: Zheng, Yue, et al.
Publicado: (2022)

Neoantigens in precision cancer immunotherapy: from identification to clinical applications
por: Zhang, Qiao, et al.
Publicado: (2022)

The Value of Microbes in Cancer Neoantigen Immunotherapy
por: Tian, Junrui, et al.
Publicado: (2023)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
por: Nagaoka, Koji, et al.
Publicado: (2021)

The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021)

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets
por: Chen, Chao, et al.
Publicado: (2020)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
por: Truex, Nicholas L., et al.
Publicado: (2020)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
por: Pang, Zhi, et al.
Publicado: (2023)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

Tumour neoantigen mimicry by microbial species in cancer immunotherapy
por: Boesch, Maximilian, et al.
Publicado: (2021)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises
por: Ashi, Mohamad Omar, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms of CD8(+) T Cell Differentiation, Dysfunction and Exhaustion
por: Verdon, Daniel J., et al.
Publicado: (2020)

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
por: Cai, Yu, et al.
Publicado: (2023)

Identifying neoantigens for use in immunotherapy
por: Hutchison, Sharon, et al.
Publicado: (2018)

Main Strategies for the Identification of Neoantigens
por: Gopanenko, Alexander V., et al.
Publicado: (2020)

Neoantigens in cancer immunotherapy: quantity vs. quality
por: Wolf, Yochai, et al.
Publicado: (2023)

Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
por: Mardis, Elaine R.
Publicado: (2019)

Neoantigens: promising targets for cancer therapy
por: Xie, Na, et al.
Publicado: (2023)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
por: Shou, Jiawei, et al.
Publicado: (2022)

Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies
por: Abbott, Rebecca C., et al.
Publicado: (2020)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
por: Zhu, Yicheng, et al.
Publicado: (2021)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

Membrane-localized neoantigens predict the efficacy of cancer immunotherapy
por: Goldberger, Zoe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ne9tj5rk9m5cigquvnrs601icq